CUBT-906

N/A

Report date: 2023/12/11 16:06:42

Base Information

Drug NameCUBT-906
Drug Alias NameCUBT-906
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-NCAM1
TargetsNeural cell adhesion molecule 1
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCurative Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesCurative Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A